Agilent Technologies announced this week that it has agreed to acquire privately-held ProZyme, a provider of glycan analysis reagents, kits, and standards.
The test, which went off the market when its original seller closed shop, uses an ultracentrifuge and spectrophotometer to measure cholesterol and triglycerides.
The number of institutions offering clinical exome or genome tests to healthy individuals keeps increasing, but the practice remains controversial among medical experts.
The Alabama Genomic Health Initiative aims to recruit participants from every county in the state and provide genomic analysis and interpretation free of charge.
